Electrochemical-MS Reaction Profiling for Simulated Drug Metabolism and Redox Chemistry

EC-MS excels at capturing short-lived, highly electrophilic intermediates — quinone imines, imine methides, nitroso compounds — that react with microsomal protein within seconds of formation in a conventional incubation and are therefore missed by post-incubation LC-MS analysis. Because the electrochemical cell-to-MS transfer time is under one second, these reactive species are detected before they can react with anything except the intentionally introduced trapping agent (GSH or NAC). EC-MS also provides voltage-resolved data: by incrementing the oxidation potential stepwise, we determine the exact potential at which each metabolite first appears — information that maps to the electronic structure of the molecule and can be used to predict metabolic soft spots without any enzymatic incubation at all.

Correlation depends on the reaction mechanism. For CYP450 reactions proceeding through single-electron transfer (SET) — aromatic hydroxylation, N-dealkylation of anilines, S-oxidation, dehydrogenation of dihydropyridines, and oxidation of phenols to quinones — EC-MS generates the same products as liver microsomes, typically with 70–92% agreement depending on the compound class. For reactions requiring direct hydrogen-atom abstraction (HAT), such as O-dealkylation of non-activated alkyl ethers, EC-MS may underrepresent or miss certain metabolites. A 2025 study comparing EC-MS with liver microsomes and in vivo data for 11 psychiatric drugs reported 92% agreement for quetiapine metabolites. We recommend EC-MS as a complementary, high-speed screening tool to identify metabolic liabilities early, with key compounds advanced to hepatocyte or microsomal incubation for full isoform-specific characterization. Our metabolic soft-spot analysis service integrates both approaches for comprehensive coverage.

EC-MS directly generates the electrophilic Phase I intermediates that serve as substrates for Phase II conjugation. By introducing GSH or NAC at a mixing tee after the electrochemical cell, we form and detect GSH adducts, glucuronide conjugates, and sulfate esters within the same online EC-LC-MS run. For GSH trapping in particular, the electrochemical approach offers a key advantage over microsomal trapping: because the reactive intermediate is generated in a clean electrolyte solution rather than a protein-rich microsomal matrix, there is no competition between the trapping agent and microsomal protein nucleophiles, yielding cleaner adduct spectra and higher sensitivity for weakly electrophilic species that would otherwise escape detection.

Boron-doped diamond (BDD) is the default choice for most drug metabolism simulations because of its wide potential window (up to 3,000 mV), resistance to fouling by oxidation products, and hydroxyl-radical-mediated oxidation mechanism that best approximates CYP450 SET chemistry. Glassy carbon is preferred when a narrower potential range is sufficient and lower background current is desired for quantitative work. Platinum and gold electrodes are selected for mechanistic studies requiring specific electrocatalytic surfaces, while mercury-coated electrodes are used exclusively for reductive EC-MS (disulfide cleavage, nitro reduction). For each project, we run a short potential-sweep experiment on BDD first to map the oxidation landscape, then switch to an alternative electrode if a specific selectivity advantage is indicated.

Dissolve your compound in 10–20 mM ammonium acetate or ammonium formate (pH 5–7) at 1–10 mM concentration. Up to 20% acetonitrile or methanol as an organic co-solvent is acceptable and often necessary for poorly water-soluble compounds. Avoid chloride-containing buffers — Cl⁻ oxidizes at potentials above 1,200 mV on BDD, generating interfering signals. Avoid phosphate, Tris, and HEPES buffers (non-volatile, suppress ESI ionization). If your compound requires DMSO for initial solubilization, keep the DMSO concentration below 1% (v/v) in the final electrolyte to avoid electrochemical oxidation of DMSO itself. For trapping experiments, we prepare GSH or NAC at 100 uM–1 mM in the same electrolyte and introduce it post-cell at the mixing tee.

Yes — using a preparative electrochemical cell with a larger working electrode surface area (typically 10–50x the analytical cell), we can generate 0.1–5 mg quantities of specific oxidative metabolites for NMR structural elucidation or use as authentic standards for quantitative LC-MS/MS bioanalysis. The preparative cell operates at the oxidation potential determined from the analytical-scale voltage-resolved profiling experiment, ensuring selective generation of the target metabolite. Yield depends on the electrochemical conversion efficiency for the specific reaction, which we measure and report. Preparative EC-MS is particularly valuable when a metabolite standard is not commercially available and chemical synthesis would require months of development — the electrochemical route often delivers the standard in days.